Shu-Jian Li

Shu-Jian Li


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SCShuai Chen
Shuai Chen
XFXiao-Rui Fan
Xiao-Rui Fan
SHShuang He
Shuang He
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li

5 June 2017 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
ZCZuzhi Chen
Zuzhi Chen
ZRZhixia Ren
Zhixia Ren
WMWenli Mei
Wenli Mei
QMQiankun Ma
Qiankun Ma
YSYingying Shi
Yingying Shi
JZJiewen Zhang
Jiewen Zhang
In the present study, a novel mutation in exon 46 at codon 2304 (G2304R) of the SYNE1 gene is described in a Chinese family (proband, mother, and sister) with Emery–Dreifuss muscular dystrophy-like, which clinically manifests as muscle weakness, muscle atrophy, joint contracture, and without significant cardiac abnormalities. Clinical examination and neuroimaging of the captured target region and high-throughput sequencing were performed in a family of four generations. Muscle changes were evaluated using magnetic resonance imaging and muscle biopsies. Target region capture sequencing yielded a novel missense mutation in codon 2304 (G2304R), which is a heterozygous A to G point mutation at position 6910 (c.6910A > G) in exon 46 of SYNE1 leading to a glycine-to-arginine substitution (p.Gly2304Arg). The results were also identified by Sanger sequencing in three family members but not in the other three unaffected family members and 100 control subjects. This mutation is probably pathogenic and is the first of its kind reported in a familial Emery–Dreifuss muscular dystrophy-like.

3 November 2021 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
SCShuai Chen
Shuai Chen
JZJin‐Long Zou
Jin‐Long Zou
SHShuang He
Shuang He
WLWei Li
Wei Li
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li
Objective: Hereditary spastic paraplegia (HSP) due to ERLIN2 gene mutations was designated as spastic paraplegia 18 (SPG18). To date, SPG18 families/cases are still rarely reported. All early reported cases shared the autosomal recessive (AR) inheritance pattern. Over the past 3 years, autosomal dominant (AD) or sporadic SPG18 cases had been continuously reported. Here, we reported the clinical and genetic features of the first autosomal dominant SPG18 pedigree in Chinese.Methods: We conducted detailed medical history inquiry, neurological examinations of the proband and his family members, and charted the family tree. The proband underwent brain and cervical magnetic resonance imaging (MRI), electromyography (EMG), and whole exome sequencing. Sanger sequencing was performed to verify the genetic variation in the proband and some family members. A literature review of all reported SPG18 families/cases was carried out to summarize the clinical‐genetic characteristics of SPG18 under different inheritance patterns.Results: Four patients were clinically diagnosed as chronic spastic paraplegia in three consecutive generations with the autosomal dominant inheritance model. All the patients presented juvenile‐adolescent onset and gradually worsening pure HSP phenotype. Clinical phenotypes were consistent within the family. Whole exome sequencing in the proband identified a previously reported heterozygous c.502G > A (p.V168M) mutation in exon 8 of ERLIN2 gene. This mutation was cosegregated with the phenotype in the family and was classified as likely pathogenic according to American College of Medical Genetics and Genomics (ACMG) guidelines. To date, eight AR‐SPG18 families, five AD‐SPG18 families, and three sporadic cases had been reported. Clinical phenotype of AD‐SPG18 was juvenile‐adolescent onset pure HSP, while the phenotype of AR‐SPG18 was mostly complicated HSP with earlier onset and more severe conditions. In rare cases, the initial spastic paraplegia could evolve to rapidly progressive amyotrophic lateral sclerosis (ALS).Conclusions: We reported the first autosomal dominant SPG18 pedigree in Chinese Han population, which added more pathogenic evidence for V168M mutation. As more SPG18 cases reported, the essentials of SPG18 need to be updated in clinical practice. Special attentions should be given in gene test for upper motor neuron disorders in case of missing heterozygous mutations in ERLIN2.

12 March 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SCShuai Chen
Shuai Chen
XLXin-Liang Liang
Xin-Liang Liang
SHShuang He
Shuang He
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li

14 April 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SCShuai Chen
Shuai Chen
JZJin-Long Zou
Jin-Long Zou
SHShuang He
Shuang He
WLWei Li
Wei Li
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li